Although intracellular Ca 2+ in pancreatic -cells is the principal signal for insulin secretion, the effect of chronic elevation of the intracellular Ca 2+ concentration ([Ca 2+ ] i ) on insulin secretion is poorly understood. We recently established two pancreatic -cell MIN6 cell lines that are glucose-responsive (MIN6-m9) and glucose-unresponsive (MIN6-m14). In the present study we have determined the cause of the glucose unresponsiveness in MIN6-m14. Initially, elevated [Ca 2+ ] i was observed in MIN6-m14, but normalization of the [Ca 2+ ] i by nifedipine, a Ca 2+ channel blocker, markedly improved the intracellular Ca 2+ response to glucose and the glucose-induced insulin secretion. The expression of subunits of ATP-sensitive K + channels and voltage-dependent Ca 2+ channels were increased at both mRNA and protein levels in MIN6-m14 treated with nifedipine. As a consequence, the functional expression of these channels at the cell surface, both of which are decreased in MIN6-m14 without nifedipine treatment, were increased significantly. Contrariwise, Bay K8644, a Ca 2+ channel agonist, caused severe impairment of glucose-induced insulin secretion in glucose-responsive MIN6-m9 due to decreased expression of the channel subunits. Chronically elevated [Ca 2+ ] i , therefore, is responsible for the glucose unresponsiveness of MIN6-m14.
SUMMARY
Although intracellular Ca 2+ in pancreatic -cells is the principal signal for insulin secretion, the effect of chronic elevation of the intracellular Ca 2+ concentration ([Ca 2+ ] i ) on insulin secretion is poorly understood. We recently established two pancreatic -cell MIN6 cell lines that are glucose-responsive (MIN6-m9) and glucose-unresponsive (MIN6-m14). In the present study we have determined the cause of the glucose unresponsiveness in MIN6-m14. Initially, elevated [Ca 2+ ] i was observed in MIN6-m14, but normalization of the [Ca 2+ ] i by nifedipine, a Ca 2+ channel blocker, markedly improved the intracellular Ca 2+ response to glucose and the glucose-induced insulin secretion. The expression of subunits of ATP-sensitive K + channels and voltage-dependent Ca 2+ channels were increased at both mRNA and protein levels in MIN6-m14 treated with nifedipine. As a consequence, the functional expression of these channels at the cell surface, both of which are decreased in MIN6-m14 without nifedipine treatment, were increased significantly. Contrariwise, Bay K8644, a Ca 2+ channel agonist, caused severe impairment of glucose-induced insulin secretion in glucose-responsive MIN6-m9 due to decreased expression of the channel subunits. Chronically elevated [Ca 2+ ] i , therefore, is responsible for the glucose unresponsiveness of MIN6-m14.
The present study also suggests normalization of [Ca 2+ ] i in pancreatic -cells as a therapeutic strategy in treatment of impaired insulin secretion.
INTRODUCTION
Because intracellular Ca 2+ is involved in a variety of cellular processes such as signal transduction, gene expression, and hormone release (1) (2) (3) (4) (5) (6) , disturbed intracellular Ca 2+ homeostasis readily induces cell dysfunction (7, 8) . In pancreatic -cells, a rise in the intracellular Ca 2+ concentration ([Ca 2+ ] i ) 1 is the trigger for insulin secretion. As the extracellular glucose concentration increases, intracellular ATP is increased and the ATP-sensitive K + (K ATP ) channels are closed, depolarizing the plasma membrane and opening the voltage-dependent Ca 2+ channels (VDCCs), which allows Ca 2+ influx.
The rise in [Ca 2+ ] in the -cells triggers exocytosis of the insulin granules (9) . When the blood glucose level falls, [Ca 2+ ] i returns to basal level. In this context, persistent hyperglycemia might well cause sustained elevated [Ca 2+ ] i and abnormalities in glucose-induced insulin secretion. It has been reported that human pancreatic islets cultured with high glucose show elevated basal [Ca 2+ ] i together with loss of the glucose-induced rise in [Ca 2+ ] i and glucose-induced insulin secretion (10) . Normal pancreatic -cells exposed to high glucose exhibit an abnormal response of intracellular Ca 2+ and impaired insulin secretion (11) , which impairments also are observed in the -cells of diabetic animals (12) (13) (14) . However, the molecular basis of the effect of chronic elevation of [Ca 2+ ] i on insulin secretion has not been examined in detail, primarily because an appropriate in vitro model has not been available.
We recently established two pancreatic -cell lines with contrary features, glucose-responsive (MIN6-m9) and glucose-unresponsive (MIN6-m14), and have shown these cell lines to be useful in -cell studies (15). MIN6-m9 exhibit glucose metabolism and insulin secretion similar to normal pancreatic -cells, while MIN6-m14 exhibit abnormalities in glucose metabolism, K ATP channel activity, VDCC activity, and glucose-induced insulin secretion (15).
In the present study we have determined the factors responsible for the The cells were then washed with BSA-KRH, and pre-incubated for 30 min in the same buffer containing 1 mM glucose. Incubation was performed with various concentrations of glucose with or without other agents as indicated for 1 h at 37 C.
The drugs used in pre-culture were omitted throughout the secretion experiments.
Released insulin was measured as described previously (15). The amounts of insulin secretion were normalized by the cellular insulin contents determined by acid-ethanol extraction.
Assay for enzyme activities. For determination of glucose-phosphorylating activity, disrupted cells were centrifuged and supernatants were incubated in a triethanolamine 3A) . Lactate dehydrogenase activity, which is increased in control MIN6-m14 as compared to MIN6-m9 (14) , was not altered by nifedipine (Fig. 3B ). Furthermore, normalization of [Ca 2+ ] i had no influence on ATP production in MIN6-m14 ( Fig. 3C ).
These results demonstrate that normalization of [Ca 2+ ] i by nifedipine does not change glucose metabolism in MIN6-m14.
Electrophysiological analyses of K ATP channels and VDCCs. We then performed functional analyses of the K ATP channels and the VDCCs by patch-clamp technique.
Normalization of [Ca 2+ ] i by nifedipine significantly increased K ATP channel conductance in MIN6-m14 (Fig. 4A ). In addition, VDCC currents at the whole-cell level also were restored by normalization of [Ca 2+ ] i by nifedipine. Peak current was significantly greater in nifedipine-treated MIN6-m14 than in control MIN6-m14 (Fig. 4B) . These data show that both K ATP channel and VDCC activities are significantly improved in MIN6-m14 after normalization of [Ca 2+ ] i.
Expressions of various genes important in glucose-induced insulin secretion.
Normalization of [Ca 2+ ] i by nifedipine did not alter mRNA expression of either GK or HK (Fig. 5A ). mRNA levels of LDH were decreased after normalization of [Ca 2+ ] i (Fig. 5A ). mRNA expression of Kir6.2, the pore-forming subunit of the -cell K ATP channel, was markedly increased by treatment with nifedipine ( Fig. 5B) . SUR1, the regulatory subunit of K ATP channels, showed a slight increase in mRNA levels (Fig. 5B) .
Expression of the 1 -subunit of the VDCCs was increased strongly in MIN6-m14 after normalization of [Ca 2+ ] i , but there was no significant difference in mRNA expression of the 3 -subunit of VDCCs (Fig. 5B ).
Subcellular localization of the subunits of K ATP channels and VDCCs.
We investigated the subcellular localization of subunits of K ATP channels and VDCCs before and after normalization of [Ca 2+ ] i . Subcellular fractionation was verified by immunoblot analysis of Na + /K + -ATPase and SERCA, markers for plasma membrane and internal membrane fractions, respectively. Normalization of [Ca 2+ ] i by nifedipine increased the levels of Kir6.2 in both plasma membrane and internal membrane fractions significantly to a similar degree ( Fig. 6B ). SUR1 was somewhat increased by treatment with nifedipine but the differences were small (Fig. 6C ). Expression level of the 1 -subunit of VDCCs was increased significantly both in plasma membrane and internal membrane fractions of MIN6-m14 after normalization of [Ca 2+ ] i (Fig. 6D) , while the expression level of the 3 -subunit was unaffected by nifedipine ( Fig. 6E) .
These results indicate that the Kir6.2 subunit of K ATP channels and the 1 -subunit of VDCCs are increased at the protein level, while membrane trafficking of these channel subunits is not affected by [Ca 2+ ] i .
Effects of other Ca 2+ modulating agents on MIN6-m14 and MIN6-m9 cells. To
confirm that the improved glucose-responsiveness in MIN6-m14 after nifedipine treatment was due to the normalization of [Ca 2+ ] i , we measured the effect of diazoxide, which activates the K ATP channel and hyperpolarizes the plasma membrane, thereby inhibiting Ca 2+ influx through the VDCCs (20) . Pre-exposure of MIN6-m14 to diazoxide (300 M for 24 h) normalized [Ca 2+ ] i and restored the Ca 2+ response to glucose ( Fig. 7B) . At the same time, the glucose-induced insulin secretion also was significantly improved (Fig. 7A ). Expressions of the Kir6.2 and the 1 -subunit were increased significantly by diazoxide in both plasma membrane and internal membrane fractions in MIN6-m14 ( Fig. 7C ). We also examined the effects of Bay K8644 (1 M), 7F) . These data suggest that chronically high [Ca 2+ ] i impairs glucose responsiveness in MIN6 cells by decreasing the expression of both K ATP channels and VDCCs.
DISCUSSION
We used two clonal pancreatic -cell lines, MIN6-m9 and MIN6-m14, in the present study as models of glucose-responsive and glucose-unresponsive -cells, respectively.
We previously demonstrated decreased activities of K ATP channels and VDCCs in glucose-unresponsive MIN6-m14 (15). K ATP channels and VDCCs serve a crucial role in coupling glucose metabolism to exocytosis of the insulin granules in pancreatic -cells (18 (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) (36) . Our data show that normalization of [Ca 2+ ] i increases the expression of both K ATP channels and VDCCs. In particular, Kir6.2, the pore-forming subunit of the K ATP channels of pancreatic -cells (23), and the 1 -subunit of the VDCCs, also the pore-forming subunit of the channel (24), were strongly up-regulated at both the mRNA (Fig. 5 ) and protein levels (Fig. 6 ). Contrariwise, Bay K8644, a Ca 2+ channel agonist, decreased the expression of the Kir6.2 subunit of K ATP channels and the 1 -subunit of VDCCs (Fig. 7F) . Little is known of the regulation of these channel expressions, but it has been reported that high glucose leads to marked decreases in both Kir6.2 and SUR1 expression in isolated rat pancreatic islets as well as in the INS-1 -cell line (25) . A decrease in Kir6.2 expression also has been noted in pancreatic islets of Zucker diabetic fatty rats (26) . Furthermore, mRNA expression of the and subunits of VDCCs are down-regulated in high glucose infused rats, but diazoxide restores expression (27, 28) . mRNA levels of the 1 -subunit of VDCCs also are reduced in pancreatic -cells of Zucker diabetic fatty rats (29 trafficking of ion channel subunits is important in the functional expression of these channels at the cell surface (30) (31) (32) (33) (34) (35) (36) (37) . To evaluate the effect of intracellular Ca 2+ on membrane trafficking of the channels, we measured the protein levels of the channel subunits in different subcellular fractions. However, the relative abundance of the K ATP channel subunits and the VDCC subunits in plasma membrane fraction and internal membrane fraction was similar in MIN6-m14 before and after nifedipine treatment, indicating that membrane trafficking of these channel subunits is not affected
MIN6-m14 exhibit abnormalities not only in glucose responsiveness but also in glucose sensitivity. As in normal pancreatic islets, half-maximal insulin secretion occurs at 15 mM of glucose in MIN6-m9, while the value is below 1 mM in MIN6-m14 cells (15). Although glucose responsiveness (intracellular Ca 2+ response to glucose and amount of secreted insulin) was dramatically improved by normalization of [Ca 2+ ] i , glucose sensitivity remained unchanged ( Figs. 2A and 7A ). GK is a rate-limiting enzyme in glycolysis in -cells, and is thought to be a glucose sensor for glucose-induced insulin secretion (38, 39 ) since it has a K m higher than the physiological concentration of glucose. However, MIN6-m14 predominantly expresses HK-I, a low-Km isoform of the glucose-phosphorylating enzyme, and > 90% of the activity occurs at 0.5 mM of glucose (15), which might well lead to abnormal glucose sensitivity. Normalization of [Ca 2+ ] i did not alter the expression of two isoforms of the enzyme (Fig. 5 ) or their activities (Fig. 3A) , which might account for the unchanged glucose sensitivity of MIN6-m14 before and after normalization of 
